SCHEMBL28131928

SCHEMBL28131928

C=Cc1c(C(=O)O)cc(Cc2ccc(OC(F)F)cc2)c(C)c1C

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PTGER4 P35408 2/20 0.41
▸ MRGPRX4 Q96LA9 1/20 0.38
▸ ALDH1A1 P00352 3/20 0.37
▸ MAPT P10636 2/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ TEAD4 Q15561 1/20 0.37
▸ LMNA P02545 2/20 0.37
▸ POLB P06746 1/20 0.37
▸ TSHR P16473 2/20 0.36
▸ PPARG P37231 4/20 0.34
▸ PPARA Q07869 4/20 0.34
▸ ATM Q13315 1/20 0.34
▸ ACACB O00763 1/20 0.34
▸ NLRP3 Q96P20 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ DAGLA Q9Y4D2 1/20 0.33
▸ RXRA P19793 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17201231 0.89 LMNA (0.38) PTGER4ALDH1A1MAPTMEN1KMT2A
SCHEMBL28131930 0.86 USP2 (0.42) ALDH1A1POLBSMN1; SMN2
SCHEMBL28841115 0.81 VDR (0.40) ALDH1A1MAPTMEN1KMT2ALMNA
SCHEMBL17201299 0.80 LMNA (0.39) PTGER4ALDH1A1MAPTMEN1KMT2A
SCHEMBL17201007 0.75 SAE1 (0.41) ALDH1A1MAPTMEN1KMT2ALMNA
SCHEMBL17201130 0.74 LMNA (0.40) PTGER4ALDH1A1MAPTMEN1KMT2A
SCHEMBL28132718 0.74 RXRA (0.44) PPARARXRA
SCHEMBL17205570 0.73 CHRM1 (0.44) MEN1KMT2ASMN1; SMN2
SCHEMBL28841022 0.72 CHRM1 (0.44) ALDH1A1MAPTMEN1KMT2APPARG
SCHEMBL17201017 0.72 EPHX2 (0.36) PTGER4ALDH1A1MAPTLMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106536508-A ISOINDOLINE-1-ONE DERIVATIVES AS CHOLINERGIC MUSCARINIC M1 RECEPTOR POSITIVE ALLOESTERIC MODULATOR ACTIVITY FOR THE TREATMENT OF ALZHEIMERS DISEASE 武田药品工业株式会社 2017-03-22 — — CN disclosed
Send feedback